Puma Biotechnology, Inc., a biopharmaceutical company, announced that on April 3, 2019 the Compensation Committee of Puma’s Board of Directors approved the grant of inducement restricted stock unit awards covering an aggregate of 45,625 shares of Puma common stock to three new non-executive employees.
April 9, 2019
· 2 min read